Cargando…
Chikungunya vaccines in development
Chikungunya virus has become a global health threat, spreading to the industrial world of Europe and the Americas; no treatment or prophylactic vaccine is available. Since the late 1960s much effort has been put into the development of a vaccine, and several heterogeneous strategies have already bee...
Autores principales: | Schwameis, Michael, Buchtele, Nina, Wadowski, Patricia Pia, Schoergenhofer, Christian, Jilma, Bernd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964651/ https://www.ncbi.nlm.nih.gov/pubmed/26554522 http://dx.doi.org/10.1080/21645515.2015.1101197 |
Ejemplares similares
-
The use of frozen plasma samples in thromboelastometry
por: Schoergenhofer, Christian, et al.
Publicado: (2017) -
Angiotensin II for the treatment of vasodilatory shock: enough data to consider angiotensin II safe?
por: Buchtele, Nina, et al.
Publicado: (2018) -
Safety, tolerability, pharmacokinetics and pharmacodynamics of parenterally administered dutogliptin: A prospective dose‐escalating trial
por: Buchtele, Nina, et al.
Publicado: (2020) -
Low PCSK-9 levels Are Associated with Favorable Neurologic Function after Resuscitation from out of Hospital Cardiac Arrest
por: Merrelaar, Anne, et al.
Publicado: (2020) -
Increased Fibrinolysis as a Specific Marker of Poor Outcome After Cardiac Arrest
por: Buchtele, Nina, et al.
Publicado: (2018)